Ambev (NYSE:ABEV – Get Free Report) had its price objective reduced by equities research analysts at Barclays from $3.50 to $3.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price objective points to a potential upside of 13.16% from the company’s previous close.
A number of other research analysts also recently issued reports on ABEV. Scotiabank downgraded Ambev from a “sector outperform” rating to a “sector perform” rating in a report on Wednesday, July 15th. UBS Group set a $2.85 price objective on Ambev in a research report on Tuesday, August 11th. Weiss Ratings lowered shares of Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday. Bank of America downgraded Ambev from a “neutral” rating to an “underperform” rating and set a $3.30 price objective on the stock. in a research report on Wednesday, October 7th. Finally, Wall Street Zen upgraded shares of Ambev from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Four analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ambev has an average rating of “Reduce” and a consensus price target of $3.01.
Check Out Our Latest Report on Ambev
Ambev Trading Down 0.7%
Ambev stock traded down $0.02 during trading hours on Friday, reaching $2.65. The company had a trading volume of 1,702,479 shares, compared to its average volume of 26,410,248. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.02 and a quick ratio of 0.76. The company has a 50-day moving average price of $3.03 and a 200 day moving average price of $3.02. The firm has a market cap of $41.78 billion, a price-to-earnings ratio of 13.22, a P/E/G ratio of 1.75 and a beta of 0.58. Ambev has a 12-month low of $2.28 and a 12-month high of $3.45.
Ambev (NYSE:ABEV – Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.05. Ambev had a return on equity of 17.48% and a net margin of 18.47%. The company had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $4.21 billion. Equities analysts forecast that Ambev will post 0.21 earnings per share for the current year.
Insider Buying and Selling
In other news, insider Carla Smith De Vasconcellos Crippa Prado sold 60,757 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $3.09, for a total transaction of $187,739.13. Following the completion of the transaction, the insider directly owned 80,707 shares in the company, valued at approximately $249,384.63. This represents a 42.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Hedge Funds Weigh In On Ambev
Several institutional investors have recently modified their holdings of ABEV. ARGA Investment Management LP raised its holdings in Ambev by 5.3% in the third quarter. ARGA Investment Management LP now owns 1,299,756 shares of the company’s stock valued at $3,795,000 after acquiring an additional 65,648 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Ambev by 29.9% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 477,339 shares of the company’s stock worth $1,394,000 after buying an additional 109,796 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Ambev during the third quarter worth about $220,000. Vise Technologies Inc. increased its position in shares of Ambev by 155.5% in the third quarter. Vise Technologies Inc. now owns 153,858 shares of the company’s stock valued at $449,000 after buying an additional 93,636 shares in the last quarter. Finally, VestGen Advisors LLC lifted its holdings in shares of Ambev by 29.2% in the third quarter. VestGen Advisors LLC now owns 16,267 shares of the company’s stock valued at $48,000 after purchasing an additional 3,679 shares in the last quarter. Institutional investors and hedge funds own 8.13% of the company’s stock.
Ambev News Summary
Here are the key news stories impacting Ambev this week:
- Positive Sentiment: Ambev’s board approved a two-year program to repurchase up to 190 million shares. The company also completed its previous buyback and canceled 279 million repurchased shares, which could support earnings per share and shareholder returns. Ambev reports third-quarter results and approves share buyback program
- Positive Sentiment: Third-quarter revenue increased year over year, with management characterizing the company as delivering consistent growth despite challenging market conditions. Ambev delivers consistent growth in challenging markets
- Neutral Sentiment: Ambev reported adjusted earnings of $0.05 per share, matching the consensus estimate. Management discussed the quarterly performance and operating conditions during the earnings call. Ambev Q3 2026 earnings call transcript
- Negative Sentiment: Revenue of approximately $4.17 billion fell short of the roughly $4.21 billion analyst consensus, limiting the market’s reaction to the reported top-line growth. Ambev fiscal third-quarter earnings
- Negative Sentiment: Ambev’s third-quarter profit declined about 10% year over year. The earnings deterioration, together with the revenue miss, appears to be the main reason the stock has decreased despite the buyback announcement. Ambev profit falls in third quarter
About Ambev
Ambev SA is a Brazilian beverage company headquartered in São Paulo and one of the largest beverage producers in Latin America. Its principal business is the production, distribution and sale of beer, although it also offers soft drinks, carbonated beverages, bottled water, energy drinks and other non-alcoholic products.
The company’s beer portfolio includes brands such as Brahma, Skol, Antarctica, Bohemia, Original, Budweiser, Stella Artois and Corona, with brand availability varying by market.
Read More
- Five stocks we like better than Ambev
- Advanced Micro Devices’ Meta Platforms Partnership Goes Beyond a $1 Billion Investment
- Chipotle’s $32 Floor: Is a Major Stock Rebound Coming?
- SaaS-Pocalypse II: Is ServiceNow’s Sell-Off Another Buying Opportunity?
- Robinhood Stock Is Down Nearly 37%—So Why Is Wall Street Still So Bullish?
Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.
